Wikidata

(Q34424631)

English

A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancer.

scientific article

In more languages

Statements

title
A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
24926548
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24926548%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34424631&oldid=1973701165"